Medtech Matters
En podkast av Medical Product Outsourcing
154 Episoder
-
3 Most Common Premarket (Postmarket?) Review Issues FDA Sees
Publisert: 25.6.2025 -
Why Are One-Third of MAUDE Reports a Problem?
Publisert: 10.6.2025 -
FDA Guidance on Off-Label Communication, Part 2
Publisert: 30.5.2025 -
FDA Guidance on Off-Label Communication, Part 1
Publisert: 30.5.2025 -
Development Considerations for Over-the-Counter Medtech, Part 1
Publisert: 23.1.2025 -
Development Considerations for OTC Medtech, Part 2
Publisert: 23.1.2025 -
Device Descriptions in Regulatory Submissions
Publisert: 7.1.2025 -
Regulatory Ramifications Due to the Presidential Election
Publisert: 26.11.2024 -
Regulatory Considerations with an Assisted Suicide Machine
Publisert: 20.11.2024 -
Predetermined Change Control Plans, Part 2
Publisert: 24.9.2024 -
Predetermined Change Control Plans, Part 1
Publisert: 24.9.2024 -
What is a CAPA and How Do You Best Use It?
Publisert: 3.9.2024 -
You Got a 483 from the FDA. Now what?
Publisert: 22.8.2024 -
Revisiting Real-World Evidence
Publisert: 18.6.2024 -
The Most Dangerous Devices to Hit the Market
Publisert: 11.6.2024 -
Headline-Generating Medical Device Safety Concerns
Publisert: 2.5.2024 -
Analyzing ECRI’s 2024 Top 10 Health Technology Hazards
Publisert: 19.3.2024 -
Examining Institutional Review Boards
Publisert: 6.3.2024 -
Reimbursing Breakthrough Designation Products
Publisert: 2.1.2024 -
Strengthening the 510k Program
Publisert: 19.12.2023
A podcast focused on the medical device technology industry, from design and development to outsourcing services and relationships to finished medtech products.
